Merck & Company, Inc. News Headlines

MRK 
$47.75
*  
0.05
  negative  
0.1%
Get MRK Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

No News Becoming Bad News For Lexicon Pharmaceuticals
4/30/2013 3:20:14 PM - SeekingAlpha

Diabetes Risk Sharing Moves Up A Gear
4/30/2013 1:23:00 PM - Seeking Alpha

Merck Wins Fosamax Trial Involving Atypical Femur Fracture Claims
4/29/2013 6:36:00 PM - RTT News

Merck Likely to Beat 1Q Earnings - Analyst Blog
4/29/2013 4:50:44 PM - Zacks.com

Pfizer Likely to Report In Line Earnings - Analyst Blog
4/29/2013 4:50:14 PM - Zacks.com

United Parcel to Buy CEMELOG - Analyst Blog
4/29/2013 2:49:47 PM - Zacks.com

Healthcare ETF in Focus on Earnings Reports - ETF News And Commentary
4/29/2013 11:51:37 AM - Zacks.com

Merck and Pfizer Agree to Develop Type 2 Diabetes Treatment
4/29/2013 8:04:00 AM - Dow Jones Business News

Merck, Pfizer Reach Deal To Develop And Commercialize Ertugliflozin In Worldwide
4/29/2013 7:42:00 AM - RTT News

A Fishing Trip To The Dividend Lake
4/29/2013 7:23:00 AM - Seeking Alpha

MARKET SNAPSHOT: Data To Overtake Earnings As May Looms
4/28/2013 8:05:00 AM - Dow Jones Business News

Wine Country Video: Short-Selling Guru Jim Chanos - "China: The Edifice Complex"
4/27/2013 1:20:27 PM - GuruFocus

Has Gold Ended Decade-Long Bull Run?
4/27/2013 1:20:08 PM - GuruFocus

Busy Week on Tap with Jobs Report, FOMC
4/26/2013 4:40:00 PM - Fox Business

WEEK AHEAD: Facebook Earnings, Fed Meeting, April Payroll Data
4/26/2013 3:53:00 PM - Dow Jones Business News

10 JPMorgan New Sovereign Dogs Bare 5.2% To 39.3% Net Gains In April
4/26/2013 3:11:00 PM - Seeking Alpha

The 3 Drivers Behind The Big Pharma Rally
4/25/2013 5:49:00 PM - Seeking Alpha

FDA Designation for Merck Candidate - Analyst Blog
4/25/2013 5:10:33 PM - Zacks.com

2nd UPDATE: Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales
4/25/2013 11:47:00 AM - Dow Jones Business News

The Dow Weekly: 5 Highest-Profit Margin Stocks
4/24/2013 3:57:00 PM - Seeking Alpha

UPDATE: FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/24/2013 10:10:00 AM - Dow Jones Business News

Merck's Lambrolizumab Designated As A Breakthrough Therapy By FDA
4/24/2013 9:48:00 AM - RTT News

Merck: Here Is What You Should Do At The 52-Week High
4/24/2013 9:03:00 AM - Seeking Alpha

Merck Gets Breakthrough Therapy Designation for Lambrolizumab
4/24/2013 8:25:00 AM - Dow Jones Business News

The Real Bad Dogs Of Dividend Investment
4/24/2013 5:21:00 AM - Seeking Alpha